Section 3, Lecture 2

Similar documents
Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Hypertension (JNC-8)

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

sympatholytics sympatholytics sympatholytics

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Management of Hypertension

Antihypertensive Agents

Beta 1 Beta blockers A - Propranolol,

DRUGS USED TO TREAT HYPERTENSION BY ALI ALALAWI

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

Antihypertensive drugs: I. Thiazide and other diuretics:

What in the World is Functional Medicine?

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

Treatment of Essential Hypertension

Hypertension Management - Summary

Antihypertensives. Diagnostic category

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

University of Al Qadisiyah College of Pharmacy Dr. Bassim I Mohammad, MBChB, MSc, Ph.D

Antihypertensive Drugs. Nafrialdi

Treatment of Essential Hypertension

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

Antihypertensive Agents

Hypertension. Penny Mosley MRPharmS

ANTIHYPERTENSIVE AGENTS AND VASODILATORS. Lecture 5

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Difficult to Treat Hypertension

Antihypertensive Agents

State of the art treatment of hypertension: established and new drugs. Prof. M. Burnier Service of Nephrology and Hypertension Lausanne, Switzerland

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

Chapter 2 ~ Cardiovascular system

HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL

1. Despite the plethora of new ACE-inhibitors they offer little advantage over the earlier products captopril and enalapril.

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Guideline-Directed Medical Therapy

ANGIOTENSIN II RECEPTOR BLOCKERS: MORE THAN THE ALTERNATIVE PRESENTATION BY: PATRICK HO, USC PHARM D. CANDIDATE OF 2017 MENTOR: DR.

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

Byvalson. (nebivolol, valsartan) New Product Slideshow

Cardiovascular drugs

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Amlodipine plus Lisinopril Tablets AMLOPRES-L

Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Heart Failure Clinician Guide JANUARY 2018

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Blood pressure (BP) control. Hypertension

PRODUCT CIRCULAR. Tablets COZAAR (losartan potassium) I. THERAPEUTIC CLASS II. INDICATIONS III. DOSAGE AND ADMINISTRATION PAK-CZR-T

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

ANTIHYPERTENSIVE DRUGS

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100

Cardiovascular Clinical Practice Guideline Pilot Implementation

Categories of HTN. Overview of Hypertension. Types of Hypertension

TREATMENT OF HYPERTENSION

By Prof. Khaled El-Rabat


LESSON ASSIGNMENT. After completing this lesson you will be able to:

Network Hypertension Algorithm

Drug Treatment of Ischemic Heart Disease

Managing Hypertension in 2016

Heart Failure (HF) Treatment

M2 TEACHING UNDERSTANDING PHARMACOLOGY

ANTI- HYPERTENSIVE AGENTS

Hypertension Pharmacotherapy: A Practical Approach

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Heart Failure Clinician Guide JANUARY 2016

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

Hypertension is also an important risk factor in the development of chronic kidney disease and heart failure.

Hypertension: an overview of recommended treatment John Vann Jones PhD, FRCP

STANDARD treatment algorithm mmHg

Antihypertensive Drugs. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014

Preventing and Treating High Blood Pressure

0BCore Safety Profile. Pharmaceutical form(s)/strength: Film-coated tablet 40, 80, 160, 320 mg SE/H/PSUR/0024/003 Date of FAR:

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

Drug Treatment of Ischemic Heart Disease

Protocol for Angiotensin converting enzyme inhibitors (ACEIs) poisoning management

Angiotensin-converting enzyme inhibitor (ACEI)

Modern Management of Hypertension: Where Do We Draw the Line?

Pharmacotherapy of Angina Pectoris

DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC

Managing Hypertension in Diabetes Sean Stewart, PharmD, BCPS, BCACP, CLS Internal Medicine Park Nicollet Clinic St Louis Park.

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Pharmacotherapy of Angina Pectoris

LOZAR. Composition Each tablet contains Losartan potassium 50 mg.

Cardiovascular Pharmacotherapy

Anti-hypertensive agents

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Transcription:

59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect against osteoporosis Loop diuretics -used in patients with poor kidney function where thiazide derivatives will not be effective 1

vasodilators β-antagonists α-antagonists Angiotensin II receptor antagonists β-antagonists β- antagonists CNS-directed sympatholytics ACE inhibitors Angiotensin II receptor antagonists diuretics 2

Potassium-Sparing Diuretics -mild diuretic and antihypertensive effect -Minimize renal-k + loss thus preventing hypokalemia -If the patient can t tolerate these drugs then use thiazide and take KCl tablets Drug Classification Diuretics Thiazide and loop diuretics Common Adverse Effects Blood cell deficiencies, hyperlipidemia, hyperuricemia, hypokalemia, and other electrolyte changes Aggravation of diabetes Common Drug Interactions Increase serum levels of lithium. Hypotensive effect decreased by NSAIDs and augmented by ACE inhibitors Potassium-sparing diuretics Hyperkalemia Hyperkalemic effect increased by ACE inhibitors and potassium supplements 3

Sympatholytics Drug Classification Adrenergic receptor antagonists α-adrenergic receptor antagonists β-adrenergic receptor antagonists Centrally acting drugs Clonidine Guanabenz Guanfacine Methyldopa Common Adverse Effects Dizziness, first-dose syncope, fluid retention, and orthostatic hypotension Bradycardia, bronchoconstriction, depression, fatigue, impaired glycogenolysis, and vivid dreams Dry mouth, fatigue, rebound hypertension, and sedation Same as clonidine Same as clonidine but milder Autoimmune hemolytic anemia, hepatitis, and lupuslike syndrome. Other adverse effects same as those of clonidine Common Drug Interactions Hypotensive effect increased by β-adrenergic receptor antagonists and diuretics Cardiac depression increased by diltiazem and verapamil. Hypotensive effect decreased by NSAIDs Hypotensive effect decreased by tricyclic antidepressants Sedative effect increased by CNS depressants Same as clonidine Same as clonidine Hypotensive effect increased by levodopa. Other interactions same as those of clonidine 4

vasodilators β-antagonists α-antagonists Angiotensin II receptor antagonists β-antagonists β- antagonists CNS-directed sympatholytics ACE inhibitors Angiotensin II receptor antagonists diuretics 5

Angiotensin Inhibitors Drug Oral Bioavailabili ty Absorption Reduced by Food Active Metabolite Duration of Action (Hours) Angiotensin-converting enzyme inhibitors Benazepril 37% No Benazeprilat Captopril 75% 30-40% None 12-Jun Enalapril 60% No Enalaprilat* Fosinopril 36% No Fosinoprilat Lisinopril 25% No None Quinapril 60% 25-30% Quinaprilat Ramipril 55% No Ramiprilat Angiotensin receptor antagonists Losartan 33% 10% Carboxylic acid metabolite Valsartan 25% 40% None Candesartan 15% No None 6

Angiotensin inhibitors 1. ACE inhibitors 2. Angiotensin receptor inhibitors Renin secretion induced by: 1-Symp. Outflow 2-reduction in BP and wall tension in renal arterioles 3-reduced NaCl reabsorbtion AT 1 AT 1 G-proteins IP3 7

ACE inhibitors Adverse effects Increase fetal morbidity and mortality, especially during 2 nd and 3th trimesters Renal failure in patients with bilateral renal artery stenosis 8

Drug Classification Angiotensin inhibitors Common Adverse Effects Common Drug Interactions Angiotensin-converting enzyme (ACE) inhibitors Angiotensin receptor antagonists Acute renal failure, angioedema, cough, hyperkalemia, loss of taste, neutropenia, and rash Hyperkalemia Increase serum levels of lithium. Hyperkalemic effect increased by potassiumsparing diuretics and potassium supplements. Hypotensive effect decreased by NSAIDs Serum levels of drug increased by cimetidine and decreased by phenobarbital 9

Vasodilators Organic nitrites and nitrates Amyl nitrites; (nitrites), administered by inhalation Nitroglycerin (glyceryl trinitrate); sublingual, oral or transdermal administration Calcium channel blockers Amlodipine, felodipine Diltiazem, verapamil 10

Tolerance Aldehyde dehydrogenase releases NO from nitroglycerin, and this process is accompanied with formation of superoxide anion free radical (O 2 - ) that in turn, deactivate aldehyde dehydrogenase -to avoid periodically interrupt the administration of the drugs Pills sublingual Sustained release- patches, skin ointments, IV Adverse effects- headaches, hypotension, dizziness, reflex tachycardia, use β-blocker in combination 11

Ca 2+ - channel blockers (CCBs) Suppress cardiac activity and relax smooth muscles-in combination increase coronary blood flow Side effects: fatigue, headache, dizziness, flushing, peripheral edema Occasionally cause gingival hyperplasia 12

Selection of Antihypertensive Drugs for Patients with Specific Traits or Concurrent Diseases Patient Characteristic Age over 65 years African heritage Pregnant Angina pectoris Myocardial infarction Congestive heart failure Recurrent stroke prevention Chronic kidney disease Diabetes Asthma Benign prostatic hyperplasia Migraine headache Osteoporosis Most Preferred Drugs Diuretic, ACEI, CCB Diuretic, CCB Methyldopa, labetalol β-blocker, CCB β-blocker, ACEI, aldosterone antagonist Diuretic, ACEI, ARB, β-blocker Diuretic, ACEI, ARB ACEI, ARB Diuretic, ACEI, ARB, β-blocker, CCB CCB, ACEI α-blocker β-blocker, CCB Diuretic Least Preferred Drugs Centrally acting α2 agonist β-blocker ACEI, ARB Hydralazine, minoxidil β-blocker 13